APR 29, 2018 6:21 AM PDT

Hypothalamic Neurons in the Obese are Different

WRITTEN BY: Carmen Leitch

The hypothalamus is a part of the brain that plays essential roles in hunger and satiety. Researchers have learned more about the neurons in that region. Scientists took skin and blood cells from healthy and very obese people and used them to create neurons that mimic those in the hypothalamus. The researchers found that when neurons are derived from cells of the obese, those neurons would not respond correctly to signals that indicate hunger or food intake; they showed differences in genes and metabolic pathways related to obesity. The data has been reported in Cell Stem Cell.

This image shows two types of iPSC-derived hypothalamic neurons: α-melanocyte stimulating hormone (α-MSH) neurons (magenta) and neurophysin II neurons (cyan). α-MSH is involved in appetite control and energy expenditure, while neurophysin II is involved in regulating blood pressure and milk production. / Credit: Uthra Rajamani and Dhruv Sareen at the Cedars-Sinai Board of Governors Regenerative Medicine Institute

"This is the first step in applying an iPSC-based platform to model complex polygenic diseases such as obesity," said senior author Dhruv Sareen, a stem cell biologist at Cedars-Sinai Medical Center. "We developed a great platform that could potentially be used to evaluate the effects of experimental therapeutics on patient-specific hypothalamic neurons from obese patients with different, genetic backgrounds, body mass index, and environmental exposures."

Most people that are obese carry gene variations that make slight contributions to their susceptibility to weight gain; those genes are often related to metabolism and food consumption. The researchers wanted to learn more about how the hypothalamus contributes to obesity, but that (brain) tissue is difficult to obtain from people.

Sareen and colleagues overcame that hurdle by finding a way to make neurons like those in the hypothalamus from other cell types. 

Their technique used blood and skin cells to generate hiPSCs (human induced pluripotent stem cells, described the video) from people with a body mass index (BMI) over 50, and those with a BMI under 25, considered normal weight. The hiPSCs then were utilized to make neurons with gene expression profiles that were similar to that of hypothalamus cells post-mortem (the profiles we have easy access to).

Those neurons release neuropeptides that respond to two hormones, ghrelin and leptin. In the neurons made from obese people, there was a stronger than typical reaction to ghrelin. The neurons also showed signs of disrupted metabolic pathways. These specialized hiPSCs are another step forward, showing how they can model disease in unusual or hard-to-obtain tissue types.

"Ultimately, we are paving the way for personalized or precision medicine, in which drugs could be customized for obese patients with different genetic backgrounds and metabolic disease status, depending on their tolerance and reaction to drug combinations," noted Sareen.

The hypothalamus does not regulate hunger on its own, however. Sareen and his team are aware of the limitations of their study, and in the future want to see how their hypothalamic-like neurons interact with other important cell types.

"There are several intermediate steps before we can realize the potential of this iPSC technology to become a reliable platform to screen potential therapeutics for obesity and other metabolic diseases,” added Sareen.

This is a fluorescence microscopy image of the hypothalamus arcuate nucleus with POMC neurons in green. / Credit: Alicia G Gómez-Valadés

 

Sources: AAAS/Eurekalert! Via Cell Press, Cell Stem Cell

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 08, 2019
Genetics & Genomics
DEC 08, 2019
Finding a Way to Treat Dangerous Protein Aggregates
The scientists are hopeful that this work will lead to new therapeutics for neurodegenerative disease....
DEC 09, 2019
Immunology
DEC 09, 2019
Strep Throat Bacteria "Hides" from the Immune System
Group A Streptococcus (GAS), the bacterial species famous for sore throat infections, have a secret weapon for circumventing the immune response to bacteri...
DEC 15, 2019
Genetics & Genomics
DEC 15, 2019
Making T-Cell Therapy Even More Effective
Curated w/video - CRISPR/Cas9 deletion of an enzyme resulted in longer lasting, more robust therapy....
JAN 07, 2020
Immunology
JAN 07, 2020
"Good" T Cells Can Go "Bad," But in the Case of Cancer, That's A Good Thing
T cells may be able to reach their full potential in the fight against cancer with a little nudge. In 2010, scientists first observed CD4+ T cells transiti...
JAN 08, 2020
Cell & Molecular Biology
JAN 08, 2020
In a First, Scientists Generate Early Human Immune Cells in the Lab
Now we know more about the early stages of the human immune system....
FEB 13, 2020
Immunology
FEB 13, 2020
Protein that suppresses immune system linked to lupus
  A study published in Human Immunology has described, for the first time, a link between an immunosuppressive protein on the surface of T cells and t...
Loading Comments...